Handa Pharmaceuticals, Inc.

Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Tainan, Taiwan, primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. Established in 2014, the company’s core focus lies in the advancement of niche drugs, particularly the development of 505(b)(2) new drug applications and high-barrier, patentable generic medications. Using its Taiwan headquarters as a global R&D hub, Handa Pharmaceuticals integrates proprietary pharmaceutical development platforms with robust capabilities in patent analysis, regulatory strategy, and market planning to address unmet medical needs. Its portfolio encompasses complex products such as controlled-release formulations and products that are challenging to develop, with a significant emphasis on neuroscience and oncology therapeutics. Handa Pharmaceuticals distributes its products predominantly in major global markets, including the United States, Canada, and India. The company’s strategic vision is to become a leading global specialty pharmaceutical innovator, improving patient outcomes through advanced drug technology and differentiated, high-value medicines.